Andre Bachmann
6Patents
2h-index
7Co-inventors
44Inventor score
Filing activity: Jun 13, 1989 → Feb 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5091315A | Bioconversion reactor | Emerging Cross-Sectional Technologies | 25 | Expired |
| US9072778B2 | Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors | Human Necessities | 11 | Active |
| US11273137B2 | Methods and compositions to prevent and treat disorders associated with mutations in the ODC1 gene | Chemistry; Metallurgy | 1 | Active |
| US12194010B2 | Methods and compositions to prevent and treat disorders associated with mutations in the ODC1 gene | Chemistry; Metallurgy | 0 | Active |
| US10584105B2 | Immunoproteasome inhibitor analogs | Chemistry; Metallurgy | 0 | Active |
| US8597904B2 | Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.